| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |